1. CCAT1 lncRNA is chromatin-retained and post-transcriptionally spliced
    Chaya Bohrer et al, 2024, Histochemistry and Cell Biology CrossRef
  2. Identification of LncRNA CARD8-AS1 as a Potential Prognostic Biomarker Associated With Progression of Lung Adenocarcinoma
    Yong Ji et al, 2022, British Journal of Biomedical Science CrossRef
  3. A Pan-Cancer Analysis of Transcriptome and Survival Reveals Prognostic Differentially Expressed LncRNAs and Predicts Novel Drugs for Glioblastoma Multiforme Therapy
    Rongchuan Zhao et al, 2021, Frontiers in Genetics CrossRef
  4. LncRNA-ENST00000421645 Upregulates Kank1 to Inhibit IFN-γ Expression and Promote T Cell Apoptosis in Neurosyphilis
    Kai-Xuan Wu et al, 2021, Frontiers in Microbiology CrossRef
  5. Super-enhancer landscape rewiring in cancer: The epigenetic control at distal sites
    Eros Di Giorgio et al, 2023, Epigenetic Regulation of Cancer - Part A CrossRef
  6. Non-coding RNA in cancer
    Chung Chau Hon et al, 2021, Essays in Biochemistry CrossRef
  7. Advances in understanding of mechanism of long non-coding RNA SNHG16 in digestive system tumors
    Hui Ye et al, 2024, World Chinese Journal of Digestology CrossRef
  8. Mutual connected IL-6, EGFR and LIN28/Let7-related mechanisms modulate PD-L1 and IGF upregulation in HNSCC using immunotherapy
    Junjun Li et al, 2023, Frontiers in Oncology CrossRef
  9. The essential roles of lncRNAs/PI3K/AKT axis in gastrointestinal tumors
    Penghui Li et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
  10. The regulatory process and practical significance of non-coding RNA in the dissemination of prostate cancer to the skeletal system
    Hui Sang et al, 2024, Frontiers in Oncology CrossRef
  11. Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1
    Xiaohui Li et al, 2020, Cancer Biology & Therapy CrossRef
  12. Comprehensive landscape and future perspectives of non-coding RNAs in esophageal squamous cell carcinoma, a bibliometric analysis from 2008 to 2023
    Jiaxin Wu et al, 2024, Pathology and Oncology Research CrossRef